P.J. Barter

Familial hypercholesterolaemia: A model of care for Australasia

Gerald F. Watts, David Sullivan, Nicola Poplawski et al. · Atherosclerosis Supplements · 2011 · 200 citations

Family Medicine, Familial Hypercholesterolaemia, Hyperlipidemia +2

Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients With Type 2 Diabetes

Sanjay Patel, Brian G. Drew, Shirley Nakhla et al. · Journal of the American College of Cardiology · 2009 · 197 citations

Inflammation, Metabolic Syndrome, High-density Lipoprotein +11

Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

Gregory G. Schwartz, Anders Olsson, Christie M. Ballantyne et al. · American Heart Journal · 2009 · 182 citations

Thrombosis, Cardiovascular Disease, Dal-outcomes Trial +12

C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy

Rishi Puri, Steven E. Nissen, Peter Libby et al. · Circulation · 2013 · 127 citations · Full text

Effects of torcetrapib in patients at high risk for coronary events

P.J. Barter, Mark J. Caulfield, Marie Eriksson · Journal of Vascular Surgery · 2008 · 109 citations · Full text

Cardiovascular Epidemiology, Cardiovascular Disease, Cardiology +11